Key result
Higher preoperative NLR predicts ~44% greater late NVAF recurrence risk alongside hs-CRP and LAD.
Why the study?
The predictive values of lipid levels, inflammatory biomarkers, and echocardiographic parameters for late NVAF recurrence after radiofrequency ablation were unclear.
Do preoperative NLR, hs-CRP, and LAD predict late NVAF recurrence after radiofrequency ablation in patients with paroxysmal or persistent NVAF?
Cohort (n=263)
No
Do preoperative NLR, hs-CRP, and LAD predict late NVAF recurrence after radiofrequency ablation in patients with paroxysmal or persistent NVAF?
Hazard Ratio: 1.438 (95% CI 1.036–1.995)
p-value: p=<0.05
The combination of preoperative NLR, hs-CRP, and LAD provides modest predictive value for late recurrence of nonvalvular atrial fibrillation after radiofrequency ablation.
May aid post-RFA recurrence risk stratification; leaves open prospective validation before clinical adoption.
BACKGROUND The purpose of this study was to evaluate the predictive values of lipid level, inflammatory biomarkers, and echocardiographic parameters in late NVAF (nonvalvular atrial fibrillation) recurrence after RFA (radiofrequency ablation). MATERIAL AND METHODS This retrospective single-center study enrolled 263 patients with paroxysmal or persistent NVAF who underwent initial RFA from Jan 2017 to Jan 2019. The patients were divided into a Recurrent group (n=70) and a Nonrecurrent group (n=193). Univariate and multivariate logistic regression analyses were used for evaluating the predictive factors of late NVAF recurrence. Receiver operating characteristic (ROC) curves were constructed to assess the predictive performance and the optimum cut-off level of variables. RESULTS Late NVAF recurrence occurred in 70 patients (26.6%) after initial RFA within 12-month follow-up. Patients in the Recurrent group had significant higher NLR (neutrophil-to-lymphocyte ratio), hs-CRP (high-sensitivity C-reactive protein), LVEDD (left ventricular end-diastolic dimension), LVESD (left ventricular end-systolic dimension), and LAD (left atrial diameter) than those in the Nonrecurrent group (P<0.05). In multivariate analysis, increased NLR (HR=1.438, 95% CI: 1.036-1.995, P<0.05), hs-CRP (HR=1.137, 95% CI: 1.029-1.257, P<0.05) and LAD (HR=1.089, 95% CI: 1.036-1.146, P<0.05) were independent predictors of NVAF recurrence. The area under the curve (AUC) of NLR and hs-CRP was 0.603 (95% CI 0.525-0.681) and 0.584 (95% CI 0.501-0.666), respectively. The combination of NLR, hs-CRP, and LAD revealed an AUC of 0.684 (95% CI 0.611-0.757), with cut-off values of 2.33, 2.025 ng/L, and 44.5 mm, respectively. CONCLUSIONS The combination of preoperative NLR, hs-CRP, and LAD can predict late NVAF recurrence.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted a cohort in Nonvalvular atrial fibrillation (n=263). Preoperative neutrophil-to-lymphocyte ratio (NLR), hs-CRP, and left atrial diameter (LAD) vs. Lower levels was evaluated on Late nonvalvular atrial fibrillation recurrence (HR 1.438, 95% CI 1.036-1.995, p=<0.05). Increased preoperative neutrophil-to-lymphocyte ratio (HR 1.438; 95% CI 1.036-1.995), hs-CRP, and left atrial diameter independently predicted late nonvalvular atrial fibrillation recurrence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: